Description
Chronic lymphocytic leukemia
IMMUNOPHENOTYPING- CLL COMPREHENSIVE PANEL
Chronic lymphocytic leukemia
TAT:
Specimen Type:
Flowcytometry Panel Test
Other Tests
-
231%
CD 34 COUNT
Enumeration of viable CD34 positive stem cells according to ISHAGE guidelines. Single platform method.
CD 34 COUNT
Enumeration of viable CD34 positive stem cells according to ISHAGE guidelines. Single platform method.
-
233%
CD34 AND CD3 CELL COUNT – HARVEST SAMPLE (HRVST)
Enumeration of viable CD34 positive stem cells according to ISHAGE guidelines. Single platform method.
CD34 AND CD3 CELL COUNT – HARVEST SAMPLE (HRVST)
Enumeration of viable CD34 positive stem cells according to ISHAGE guidelines. Single platform method.
- 260%
-
272%
ZAP70
Patients with chronic lymphocytic leukemia have variable outcome. ZAP70 can predict patients who have aggressive disease and need aggressive therapy.
ZAP70
Patients with chronic lymphocytic leukemia have variable outcome. ZAP70 can predict patients who have aggressive disease and need aggressive therapy.
Reviews
There are no reviews yet.